
Agilent (A) Technologies announced the SureSelect Cancer Research Pan Heme. Developed in collaboration with experts at Roswell Park Comprehensive Cancer Center, the solution integrates DNA and RNA profiling, automated sample
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| A | Agilent | 177.33 | 29.75 | 20.16% |
| Name | Price | % Change | |
|---|---|---|---|
| $177.33 | +20.16% |

Agilent (A) Technologies announced the SureSelect Cancer Research Pan Heme. Developed in collaboration with experts at Roswell Park Comprehensive Cancer Center, the solution integrates DNA and RNA profiling, automated sample

Agilent (A) Technologies announced the successful completion of its previously announced acquisition of Proscia, a leading provider of digital-pathology software for clinical and life-sciences customers. Under the terms of the

Agilent (A) Technologies announced the launch of the 5987A single quadrupole mass selective detector with GC Assist, along with MassHunter 14 software. When combined with the Agilent 8890B or 8860B

Agilent (A) Technologies and the University of Chicago announced a scientific collaboration to establish the Agilent Center of Excellence, CoE, for Energy Materials Research. The Agilent CoE will be based

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by

Deutsche Bank analyst Justin Bowers initiated coverage of Agilent (A) with a Buy rating and $190 price target The firm believes Agilent’s has a strong position across multiple end markets

Deutsche Bank analyst Justin Bowers initiated coverage of Agilent (A) with a Buy rating and $190 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking

TD Cowen raised the firm’s price target on Agilent (A) to $196 from $180 and keeps a Buy rating on the shares. The firm adjusted targets in the life science

Agilent (A) Technologies announced it has entered into a definitive agreement to acquire Proscia, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued

Morgan Stanley raised the firm’s price target on Agilent (A) to $190 from $175 and keeps an Overweight rating on the shares as the firm refreshed models in its life
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Initiated | Oct 26, 2026 | ||||
| buy | Assigned | Oct 19, 2026 | ||||
| hold | Reiterated | Oct 14, 2026 | ||||
| buy | Assigned | Oct 13, 2026 | ||||
| buy | Assigned | Oct 13, 2026 | ||||
| buy | Reiterated | Oct 13, 2026 | ||||
| buy | Reiterated | Oct 7, 2026 | ||||
| buy | Reiterated | Sep 20, 2026 | ||||
| hold | Reiterated | Sep 17, 2026 | ||||
| buy | Reiterated | Aug 30, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Nov 23, 2026After Close | $48.55B | $1.73 | $1.99B | 9.44 | 33.72 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.